Welcome!

News Feed Item

Fc Protein and Glycoengineered Antibodies Market

DUBLIN, March 5, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and) has announced the addition of the "Fc Protein and Glycoengineered Antibodies Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies. Developed through introduction of modifications in monoclonal antibodies, the aim is to develop antibodies with improved efficacy.

Research done in the last decade to develop engineered antibodies has yielded a rich knowledge base on how to develop and market these next generation antibodies. These therapeutic antibodies seem to be more promising, with improved properties when compared to their ancestors. There are several molecules in phase II / III clinical trials and a few waiting for approvals. In addition, a large number of molecules are also in pre-clinical trials and are expected to progress through various stages of drug development over the next ten years.

The Fc Protein and Glycoengineered Antibody Market, 2013-2023 report was commissioned to examine the various aspects of engineering an antibody to develop novel drugs and address several oncology specific diseases. With the market being fairly new, the report examines several elements of developing these next generation antibodies including technologies used for their production, site of engineering in an antibody and molecules in pipeline.

For the purposes of this report, engineered antibodies are defined as antibodies which have been modified in their Fc region. The two types of modification considered are:

  • Fc Glycoengineering (referred to as Glycoengineering' in the report)
  • Fc Protein engineering

Key Topics Covered:

1. EXECUTIVE SUMMARY

2. INTRODUCTION

3. ENGINEERED ANTIBODIES: OVERVIEW AND BACKGROUND

4. GLYCOENGINEERED ANTIBODIES MARKET, 2012 - 2023

5. Fc PROTEIN ENGINEERED ANTIBODIES MARKET, 2013 - 2023

6. TECHNOLOGICAL PLATFORMS FOR ENGINEERED ANTIBODIES

7. PROFILES OF LEADING COMPANIES

8. SWOT ANALYSIS

9. CONCLUSIONS

10. APPENDIX 1: TABLES

11. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS


Companies Mentioned:

  • ABN AMRO Capital
  • AVID Bioservices
  • Absolute Antibody
  • Accurus Biosciences
  • Affitech A/S
  • Allos Therapeutics
  • Amgen
  • Andromeda Biotech
  • Applied Molecular Evolution (AME)
  • Astra Zeneca
  • BioMedinvest
  • BioWa
  • BioXcellence
  • BioXpress Therapeutics
  • Bioceros
  • Biocon
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • CSL
  • Celltrion
  • Centocor Ortho Biotech
  • Cephalon
  • ChemoCentryx
  • Chugai Pharmaceuticals
  • Deutsche Venture Capital
  • Diamyd Medical
  • Dong-A Pharmaceutical
  • Eli Lilly
  • Eureka Therapeutics
  • Five Prime Therapeutics
  • GSK
  • Genentech
  • Gilde Investment Management
  • Global Life Science Ventures
  • Glycart
  • Glycode
  • Glycotope
  • Green Cross Corporation
  • Greenovation
  • Halozyme Therapeutics
  • Hanwha Chemical
  • Human Genome Sciences
  • ISU Abxis
  • Ildong Pharmaceuticals
  • ImmunGene
  • Inhibrx
  • InvivoGen
  • KaloBios
  • Kyowa Hakko Kirin
  • Laboratoire français du Fractionnement et des Biotechnologies (LFB)
  • Life Science Pharmaceuticals
  • Lonza
  • MacroGenics
  • MedImmune
  • Meiji Seika Pharma
  • Mentrik Biotech
  • Merck-GlycoFi
  • Micromet
  • MilleGen
  • Minapharm Pharmaceuticals
  • Morphosys
  • Mylan
  • NKT Therapeutics
  • Nippon Kayaku
  • Nippon Shinyaku
  • Novartis
  • Novartis Venture Fund
  • Ortho-McNeil Janssen Pharmaceutical
  • PDL Biopharma
  • Pfizer
  • Pikamab
  • Pinnacle Oncology Hematology
  • PlantForm Corporation
  • ProStrakan
  • Quester Capital Management
  • Regeneron Pharmaceuticals
  • Roche
  • Sandoz
  • Sanofi
  • Schnell Biopharma
  • Seattle Genetics
  • Servier
  • Shanghai CP Guojian
  • SiaMedExpress
  • Sorrento Therapeutics
  • Synthon-Biolex
  • TG Therapeutics
  • Taiho Pharmaceutical
  • Teva Pharmaceuticals
  • Trubion
  • Vivalis
  • Watson Pharmaceuticals
  • WuXi AppTec
  • Xencor
  • Zymeworks
  • arGEN-X
  • biOasis Technologies
  • rEVO Biologic

For more information visit http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and


Media Contact: Laura Wood , +353-1-481-1716, [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex software systems for startups and enterprises. Since 2009 it has grown from a small group of passionate engineers and business...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Join us at Cloud Expo June 6-8 to find out how to securely connect your cloud app to any cloud or on-premises data source – without complex firewall changes. More users are demanding access to on-premises data from their cloud applications. It’s no longer a “nice-to-have” but an important differentiator that drives competitive advantages. It’s the new “must have” in the hybrid era. Users want capabilities that give them a unified view of the data to get closer to customers and grow business. The...
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
"We focus on composable infrastructure. Composable infrastructure has been named by companies like Gartner as the evolution of the IT infrastructure where everything is now driven by software," explained Bruno Andrade, CEO and Founder of HTBase, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Cloud Academy named "Bronze Sponsor" of 21st International Cloud Expo which will take place October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara, CA. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud com...
"We are a monitoring company. We work with Salesforce, BBC, and quite a few other big logos. We basically provide monitoring for them, structure for their cloud services and we fit into the DevOps world" explained David Gildeh, Co-founder and CEO of Outlyer, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, paneli...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business - from apparel to energy - is being rewritten by software. From planning to development to management to security, CA creates software that fuels transformation for companies in the applic...